Immediate Impact
1 by Nobel laureates 2 from Science/Nature 58 standout
Citing Papers
The present and future of bispecific antibodies for cancer therapy
2024 Standout
Targeting ROS in cancer: rationale and strategies
2024 Standout
Works of Tony Sabin being referenced
A Randomized Phase 2 Study of Paclitaxel and Carboplatin with or without Conatumumab for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer
2013
Predictive value of Fc gamma receptor IIIa genotype in response to conatumumab in three phase II studies.
2011
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Tony Sabin | 59 | 69 | 183 | 11 | 343 | |
| Sandesh Chopade | 11 | 22 | 145 | 8 | 378 | |
| Rebecca L. Zuvich | 16 | 54 | 85 | 10 | 395 | |
| Rupert Faraway | 7 | 19 | 192 | 11 | 360 | |
| Seonwoo Kim | 4 | 48 | 72 | 15 | 305 | |
| Xin Chen | 2 | 84 | 179 | 8 | 348 | |
| Shengkun Peng | 3 | 89 | 105 | 15 | 304 | |
| Sarah K. Martin | 7 | 90 | 215 | 7 | 407 | |
| Youngsuk Seo | 3 | 50 | 228 | 11 | 405 | |
| Hongwei Tang | 9 | 199 | 211 | 10 | 375 | |
| Tomoko Saito | 2 | 57 | 133 | 11 | 401 |
All Works
Loading papers...